Skye Bioscience Inc (SKYE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 30,193 | 34,735 | 18,312 | 7,848 | 6,289 |
| Operating Income | -30,193 | -34,735 | -18,312 | -7,848 | -6,289 |
| Interest Expense | 749 | 906 | 665 | 769 | 706 |
| Other Income | 4,385 | -2,000 | -498 | 97 | 436 |
| Pre-tax Income | -26,557 | -37,641 | -19,475 | -8,520 | -6,559 |
| Income Tax | 10 | 4 | 7 | 2 | 2 |
| Net Income Continuous | -26,567 | -37,645 | -19,482 | -8,522 | -6,561 |
| Net Income | $-26,567 | $-37,645 | $-19,482 | $-8,522 | $-6,561 |
| EPS Basic Total Ops | -0.73 | -5.37 | -8.77 | -5.00 | -7.50 |
| EPS Basic Continuous Ops | -0.73 | -5.37 | -8.77 | -5.24 | -7.11 |
| EPS Diluted Total Ops | -0.73 | -5.37 | -8.77 | -5.00 | -7.50 |
| EPS Diluted Continuous Ops | -0.73 | -5.37 | -8.77 | -5.24 | -7.09 |
| EPS Diluted Before Non-Recurring Items | -0.85 | -5.37 | -10.00 | -5.00 | -7.50 |
| EBITDA(a) | $-29,295 | $-34,281 | $-17,707 | $-7,220 | $-5,743 |